Skip to product information
1 of 1
IHC of GCDFP-15 on a FFPE Breast Carcinoma Tissue

GCDFP-15 (23A3)

US
IVD-CE
Europe
IVD-CE
International
IVD-CE
Size
Contact for price View full details

Product Information

Summary & Explanation

{"type":"root","children":[{"type":"paragraph","children":[{"type":"text","value":"Gross Cystic Disease is a common premenopausal disorder in which gross cysts are the predominant pathologic lesion. It is characterized by production of a fluid secretion which accumulates in the breast cysts. Gross Cystic Disease fluid is a pathologic secretion from breast composed of several glycoproteins, including a unique 15 kDa monomer protein, GCDFP-15. The cells within the body that produce GCDFP-15 appear to be restricted primarily to those with apocrine function such as breast cysts and in apocrine glands in the axilla, vulva, eyelid, and ear canal."}]},{"type":"paragraph","children":[{"type":"text","value":"Studies have found GCDFP-15 to be a highly specific and sensitive marker for breast cancer. Approximately 70% of breast carcinomas stain positive with antibody to GCDFP-15. In contrast, Colorectal Carcinomas, as well as Mesotheliomas, do not stain with this antibody. Lung Adenocarcinomas rarely stain with this antibody."}]}]}

Antibody Type

Mouse Monoclonal

Clone

23A3

Isotype

IgG2a

Localization

Cytoplasmic

Dilution

1:100-1:500

Species Reactivity

Human, Rat

Immunogen

Recombinant protein encoding the excreted domain of human GCDFP15.